It was proved that TNFAIP3, a key factor in NF-κB pathway, could attenuate NF-κB activation during the infection [45] while nAChR, one of important ACh receptor, could also modulate the inflammatory responses through both NF-κB and JAK/STAT pathway [46, 47]. The gene discussed is CHRNA4; the disease is infection.